Testing effectiveness (Phase 2)Study completedNCT01108445
What this trial is testing
Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
Who this might be right for
Advanced Non-clear Cell Renal Cell Carcinoma
Duke University 131